IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $844,000 | +30.7% | 22,794 | +58.7% | 0.07% | +56.5% |
| Q1 2021 | $646,000 | -23.5% | 14,360 | -19.3% | 0.05% | -68.3% |
| Q3 2020 | $844,000 | +137.1% | 17,795 | +194.4% | 0.14% | +253.7% |
| Q2 2020 | $356,000 | +1.7% | 6,044 | +11.1% | 0.04% | +95.2% |
| Q2 2019 | $350,000 | -52.3% | 5,439 | -39.8% | 0.02% | -50.0% |
| Q1 2019 | $734,000 | +10.0% | 9,041 | -40.3% | 0.04% | +16.7% |
| Q1 2018 | $667,000 | +77.4% | 15,132 | +102.4% | 0.04% | +80.0% |
| Q4 2017 | $376,000 | -70.1% | 7,476 | -69.8% | 0.02% | -67.7% |
| Q3 2017 | $1,257,000 | +513.2% | 24,789 | +648.0% | 0.06% | +113.8% |
| Q4 2015 | $205,000 | – | 3,314 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |